Skip to Content

Theralase Technologies Inc TLTFF

Morningstar Rating
$0.13 +0.01 (7.24%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TLTFF is trading within a range we consider fairly valued.
Price
$0.13
Fair Value
$6.97
Uncertainty
Extreme
1-Star Price
$6.43
5-Star Price
$4.95
Economic Moat
Wjn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TLTFF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.12
Day Range
$0.130.13
52-Week Range
$0.110.24
Bid/Ask
$0.10 / $0.13
Market Cap
$30.28 Mil
Volume/Avg
75,100 / 83,273

Key Statistics

Price/Earnings (Normalized)
Price/Sales
33.33
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
14

Valuation

Metric
TLTFF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
33.33
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
TLTFF
Quick Ratio
0.60
Current Ratio
1.39
Interest Coverage
−150.97
Quick Ratio
TLTFF

Profitability

Metric
TLTFF
Return on Assets (Normalized)
−115.95%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−155.77%
Return on Assets
TLTFF
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesZrxbksszHlvjpxv$189.3 Bil
SYK
Stryker CorpDldmkftmqZtpmh$130.1 Bil
MDT
Medtronic PLCRfqxlydJhcqmqq$109.3 Bil
BSX
Boston Scientific CorpDvnfwbvfqVwqty$100.9 Bil
EW
Edwards Lifesciences CorpMghlxrjyDzwxtt$54.3 Bil
DXCM
DexCom IncVlywdykcdHtcv$54.1 Bil
ZBH
Zimmer Biomet Holdings IncPvdmhkwhYmbz$25.6 Bil
ALGN
Align Technology IncSyylxnpHmyrwx$24.7 Bil
PHG
Koninklijke Philips NV ADRCfmsdqqjCbqjnv$18.8 Bil
PODD
Insulet CorpJswgylthjJxmnrjk$12.3 Bil

Sponsor Center